Heterogeneity of purified mouse interferons.

PubWeight™: 1.61‹?› | Rank: Top 4%

🔗 View Article (PMID 236313)

Published in J Biol Chem on June 10, 1975

Authors

E Knight

Articles citing this

Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol (2014) 3.47

Outer membrane proteins of Brucella abortus: isolation and characterization. Infect Immun (1982) 3.07

Interferon: purification and initial characterization from human diploid cells. Proc Natl Acad Sci U S A (1976) 2.45

Human leukocyte interferon: production, purification to homogeneity, and initial characterization. Proc Natl Acad Sci U S A (1979) 2.03

Large-scale production and physicochemical characterization of human immune interferon. Infect Immun (1979) 1.99

Microcapsule of Campylobacter fetus: chemical and physical characterization. Infect Immun (1978) 1.81

Large-scale production and partial purification of mouse immune interferon. Infect Immun (1979) 1.57

Biosynthesis of mouse interferon by translation of its messenger RNA in a cell-free system. Proc Natl Acad Sci U S A (1975) 1.27

Structure and properties of human interferon-alpha from Namalwa lymphoblastoid cells. Biochem J (1982) 1.07

Purification and characterization of mouse interferon with novel affinity sorbents. J Virol (1976) 0.98

Translational elongation rate changes in encephalomyocarditis virus-infected and interferon-treated cells. J Virol (1981) 0.96

Rapid quantitation of interferon with chronically oncornavirus-producing cells. Infect Immun (1976) 0.96

Specificity of interferon action in protein synthesis. J Virol (1978) 0.93

Interferoids: in vitro and in vivo conversion of native interferons to lower molecular weight forms. Proc Natl Acad Sci U S A (1978) 0.83

Multisurface glass roller bottle for growth of animal cells in culture. Appl Environ Microbiol (1977) 0.75

Ernest (Pete) Knight Jr. (1932-2013). A remembrance to a great interferon scientist and colleague. J Interferon Cytokine Res (2013) 0.75

Articles by these authors

ATP-dependent reduction of azide and HCN by N2-fixing enzymes of Azotobacter vinelandii and Clostridium pasteurianum. Biochim Biophys Acta (1967) 5.81

Transcriptional induction of two genes in human cells by beta interferon. Proc Natl Acad Sci U S A (1984) 4.84

Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A (1987) 4.61

Characterization of a new low molecular weight RNA in HeLa cell ribosomes. J Mol Biol (1968) 4.44

Reduction of N2O by biological N2-fixing systems. Biochem Biophys Res Commun (1966) 3.66

Human fibroblast interferon: amino acid analysis and amino terminal amino acid sequence. Science (1980) 2.77

Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A (1996) 2.45

Interferon: purification and initial characterization from human diploid cells. Proc Natl Acad Sci U S A (1976) 2.45

Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J Biol Chem (1986) 2.37

Interferon regulates c-myc gene expression in Daudi cells at the post-transcriptional level. Proc Natl Acad Sci U S A (1985) 2.24

Fibroblast interferon induces synthesis of four proteins in human fibroblast cells. Proc Natl Acad Sci U S A (1979) 2.01

Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J (2000) 2.01

In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol (1996) 1.98

Distribution of 5 s RNA in HeLa cells. J Mol Biol (1967) 1.78

An energy-dependent hydrogen-evolution from dithionite in nitrogen-fixing extracts of Clostridium pasteurianum. Biochem Biophys Res Commun (1965) 1.77

Interferon-induced proteins. Purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J Biol Chem (1984) 1.74

Selective reduction of c-myc mRNA in Daudi cells by human beta interferon. Proc Natl Acad Sci U S A (1984) 1.65

Support, mutual aid and recovery from dual diagnosis. Community Ment Health J (2000) 1.61

A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol (1991) 1.47

A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. Anal Biochem (1997) 1.47

Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J Neurosci (1998) 1.34

Clumsiness in children--do they grow out of it? A 10-year follow-up study. Dev Med Child Neurol (1991) 1.29

Recovery challenges among dually diagnosed individuals. J Subst Abuse Treat (2000) 1.24

Isolation and characteristics of flavodoxin from nitrogen-fixing Clostridium pasteurianum. J Biol Chem (1966) 1.23

Consumers as peer specialists on intensive case management teams: impact on client outcomes. Psychiatr Serv (1995) 1.22

Human fibroblast interferon. An improved purification. J Biol Chem (1981) 1.18

In vivo and in vitro synthesis of human rhinovirus type 2 ribonucleic acid. J Virol (1972) 1.18

Antiviral and cell growth inhibitory activities reside in the same glycoprotein of human fibroblast interferon. Nature (1976) 1.18

A cell surface alteration in mouse L cells induced by interferon. Biochem Biophys Res Commun (1977) 1.18

Orthopaedic intervention in early rheumatoid arthritis. Occurrence and predictive factors in an inception cohort of 1064 patients followed for 5 years. Rheumatology (Oxford) (2004) 1.16

Proceedings: Aortic valve replacement using fresh unstented homografts. Thoraxchir Vask Chir (1973) 1.11

Flavodoxin: a flavoprotein with ferredoxin activity from Clostrium pasteurianum. Biochim Biophys Acta (1966) 1.08

Flavodoxin. Chemical and biological properties. J Biol Chem (1967) 0.97

Chronic nutmeg psychosis. J R Soc Med (1993) 0.97

Orthodeoxia: a new finding in interstitial fibrosis. Am Rev Respir Dis (1987) 0.94

Oral anticoagulation in atrial fibrillation: A pan-European patient survey. Eur J Intern Med (2007) 0.93

The use of "fresh" unstented homograft valves for replacement of the aortic valve: analysis of 6 1/2 years experience. Circulation (1977) 0.93

Mitochondria-associated ribonucleic acid of the HeLa cell. Effect of ethidium bromide on the synthesis of ribosomal and 4S ribonucleic acid. Biochemistry (1969) 0.91

Coronary angiography Review of 1500 consecutive cases. Br Heart J (1976) 0.90

Fatal hypercalcaemia complicating carcinoma of breast, resistant to cortisone and phosphate administration. Br Med J (1967) 0.88

Interferon-Sepharose: induction of the antiviral state. Biochem Biophys Res Commun (1974) 0.87

Human interferon-beta: effects of deglycosylation. J Interferon Res (1982) 0.87

Preparation of 125iodine-labelled human fibroblast interferon. J Gen Virol (1978) 0.85

X-ray studies on phospholipid bilayers. II. Polymorphic forms of dipalmitoyl phosphatidylethanolamine. Z Naturforsch C (1983) 0.84

Interferon-beta enhances the synthesis of a 20,000-dalton membrane protein: a correlation with the cessation of cell growth. J Interferon Res (1985) 0.83

A 15-kD interferon-induced protein and its 17-kD precursor: expression in Escherichia coli, purification, and characterization. J Interferon Res (1989) 0.83

Managed care: recovery enhancer or inhibitor? Psychiatr Serv (2001) 0.83

Comparison of doxorubicin with cycloleucine in the treatment of sarcomas. Cancer Treat Rep (1981) 0.83

Vascular access for cancer chemotherapy. JAMA (1977) 0.83

Aortic valve replacement using fresh unstented homografts. Br Heart J (1973) 0.81

Impact of gavage dosing procedure and gastric content on adverse respiratory effects and mortality in rat toxicity studies. J Appl Toxicol (2010) 0.81

Interferons and the regulation of oncogenes. Interferon (1986) 0.79

Production and characterization of recombinant mouse brain-derived neurotrophic factor and rat neurotrophin-3 expressed in insect cells. J Neurochem (1994) 0.78

Transurethral resection of the prostate: still the gold standard. Aust N Z J Surg (1997) 0.78

Proceedings: Coronary angiography using Judkins method. Br Heart J (1974) 0.78

Proceedings: Late results of mitral valve replacement using "fresh" unstented aortic homografts. Thoraxchir Vask Chir (1973) 0.77

Antibodies to synthetic peptides of human interferon-beta. Use in biosynthetic studies. J Biol Chem (1984) 0.77

Interferon: effect on the saturation density to which mouse cells will grow in vitro. J Cell Biol (1973) 0.76

Transfer RNA: A comparison by gel electrophoresis of the tRNA in HeLa cytoplasm, HeLa mitochondrial fraction, and E. coli. Proc Natl Acad Sci U S A (1969) 0.75

Stimulation of Pyrophosphatase Activity in Clostridium pasteurianum by Reductants. J Bacteriol (1965) 0.75

Turnover of HeLa ribosomal RNA. The characterization of a class of RNA in HeLa cytoplasm derived from 28S RNA. J Cell Biol (1971) 0.75

Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271). Cancer Chemother Rep (1975) 0.75

A membrane protein from IFN-beta-treated Daudi cells causes a cessation in cell growth. Biochem Biophys Res Commun (1987) 0.75

[Counseling of unmarried, teenage expectant mothers]. Taehan Kanho (1965) 0.75

Ribosomal RNA associated with HeLa mitochondria. Biochim Biophys Acta (1969) 0.75

Hepatic responses to edible gums during refeeding of starved rats. J Nutr (1988) 0.75

Fused pyrrolo[2,3-c]carbazol-6-ones: novel immunostimulants that enhance human interferon-gamma activity. J Med Chem (1997) 0.75

THE APPLICATION OF FUNGI AS STYPTICS. Br Med J (1913) 0.75

Patents and literature. Appl Biochem Biotechnol (1981) 0.75

Purification of human fibroblast interferon prepared in the absence of serum. Methods Enzymol (1981) 0.75

Late results of direct myocardial revascularisation. Thoraxchir Vask Chir (1974) 0.75

E. coli transfer RNA: fractionation by electrophoresis on polyacrylamide gel. Prep Biochem (1971) 0.75

Claiming disability benefits. Health Visit (1992) 0.75

Acute nephropathy induced by gold sodium thiomalate: alterations in renal heme metabolism and morphology. Toxicol Appl Pharmacol (1987) 0.75

Effects of caffeine on cardiorespiratory function and glucose metabolism during rest and graded exercise. J Sports Med Phys Fitness (1987) 0.75

Left ventricular aneurysm: current appraisal. Br Heart J (1973) 0.75

Radioisotopes labeling of interferons. Tex Rep Biol Med (1983) 0.75

Interferon-sepharose: priming of L cells for induction of interferon by MM virus. J Gen Virol (1974) 0.75

Considerations in our search for interferons for clinical use. Adv Exp Med Biol (1978) 0.75

Characterization of radioactive human fibroblast-derived beta interferon synthesized in vivo. J Interferon Res (1981) 0.75

Proceedings: A new development in ultrasound, using a multi-transducer technique. Br Heart J (1974) 0.75

A growth inhibitory protein secreted by human diploid fibroblasts. Partial purification and characterization. J Biol Chem (1987) 0.75

A Welch-type test for homogeneity of contrasts under heteroscedasticity with application to meta-analysis. Stat Med (2004) 0.75

Dry eye therapy: evaluation of current directions and clinical trials. Adv Exp Med Biol (1994) 0.75

Postcardiac catheterization time-in-bed study: enhancing patient comfort through nursing research. Appl Nurs Res (1994) 0.75

Effects of salicylamide and protein restriction on the skeletal development of the rat fetus. Teratology (1978) 0.75

Effect of salicylamide on the placental transfer and fetal tissue distribution of sodium-35S-sulfate in the rat. J Nutr (1978) 0.75

Regulation of c-myc RNA and its proteins in Daudi cells by interferon-beta. J Interferon Res (1987) 0.75

An interferon-induced 16-kD protein is present in the membranes of interferon-sensitive but not in interferon-resistant mouse cells. J Interferon Res (1991) 0.75

In vivo radiolabeling of human IFN-beta. Methods Enzymol (1986) 0.75

Vascular access for cancer chemotherapy. Cancer (1979) 0.75